Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil

Neuropathology and Applied Neurobiology

Volumn 36, Issue 7, 2010, Pages 598-611

  Dehghani, F ^a,b   Sayan, M ^a   Conrad, A ^a   Evers, J ^a   Ghadban, C ^a,b   Blaheta, R ^a   Korf, H W ^a   Hailer, N P ^a,c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Astrocytes; Inflammation; Microglia; Mycophenolate mofetil; Nitric oxide; Proinflammatory cytokines

Indexed keywords

GUANOSINE; IMMUNOSUPPRESSIVE AGENT; INOSINE PHOSPHATE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL ISOLATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MICROGLIA; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASTROCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; GUANOSINE; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-1BETA; MICROGLIA; MICROSCOPY, CONFOCAL; MYCOPHENOLIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78349278062     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01104.x     Document Type: Article

References (45)

1. Blight AR. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992; 9 (Suppl. 1): S83-91
2. Marty S, Dusart I, Peschanski M. Glial changes following an excitotoxic lesion in the CNS - I. Microglia/macrophages. Neuroscience 1991; 45: 529-39
3. Rinner WA, Bauer J, Schmidts M, Lassmann H, Hickey WF. Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras. Glia 1995; 14: 257-66
4. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings MG, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706
5. Hurlbert RJ. Strategies of medical intervention in the management of acute spinal cord injury. Spine 2006; 31 (Suppl. 11): S16-21
6. Diaz-Ruiz A, Rios C, Duarte I, Correa D, Guizar-Sahagun G, Grijalva I, Ibarra A. Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci Lett 1999; 266: 61-4
7. Teichner A, Morselli E, Buttarelli FR, Caronti B, Pontieri FE, Venturini G, Palladini G. Treatment with cyclosporine A promotes axonal regeneration in rats submitted to transverse section of the spinal cord. J Hirnforsch 1993; 34: 343-9
8. Bavetta S, Hamlyn PJ, Burnstock G, Lieberman AR, Anderson PN. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp Neurol 1999; 158: 382-93
9. Kitamura Y, Itano Y, Kubo T, Nomura Y. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J Neuroimmunol 1994; 50: 221-4
10. Madsen JR, MacDonald P, Irwin N, Goldberg DE, Yao GL, Meiri KF, Rimm IJ, Stieg PE, Benowitz LI. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp Neurol 1998; 154: 673-83
11. Manev H, Favaron M, Candeo P, Fadda E, Lipartiti M, Milani D. Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate. Brain Res 1993; 624: 331-5
12. Klettner A, Herdegen T. FK506 and its analogs - therapeutic potential for neurological disorders. Curr Drug Targets CNS Neurol Disord 2003; 2: 153-62
13. Hailer NP, Vogt C, Korf HW, Dehghani F. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 2005; 21: 2347-60
14. Lawrence CB, Allan SM, Rothwell NJ. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 1998; 10: 1188-95
15. Vogt C, Hailer NP, Ghadban C, Korf HW, Dehghani F. Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin-1 receptor antagonist. J Neurosci Res 2008; 86: 3314-21
16. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000; 47: 85-118
17. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 1991; 33: 175-83
18. Dehghani F, Hischebeth GT, Wirjatijasa F, Kohl A, Korf HW, Hailer NP. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures. Eur J Neurosci 2003; 18: 1061-72
19. Oest TM, Dehghani F, Korf HW, Hailer NP. The immunosuppressant mycophenolate mofetil improves preservation of the perforant path in organotypic hippocampal slice cultures: a retrograde tracing study. Hippocampus 2006; 16: 437-42
20. Hailer NP, Wirjatijasa F, Roser N, Hischebeth GT, Korf HW, Dehghani F. Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N-methyl-D-aspartate-induced excitotoxic injury in organotypic hippocampal slice cultures. Eur J Neurosci 2001; 14: 315-26
21. Dehghani F, Conrad A, Kohl A, Korf HW, Hailer NP. Clodronate inhibits the secretion of proinflammatory cytokines and NO by isolated microglial cells and reduces the number of proliferating glial cells in excitotoxically injured organotypic hippocampal slice cultures. Exp Neurol 2004; 189: 241-51
22. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80
23. Wirjatijasa F, Dehghani F, Blaheta RA, Korf HW, Hailer NP. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells. J Neurosci Res 2002; 68: 579-87
24. Jonsson CA, Carlsten H. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells. Int Immunopharmacol 2003; 3: 31-7
25. Suzumura A, Sawada M, Itoh Y, Marunouchi T. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol 1994; 53: 209-18
26. Hailer NP, Grampp A, Nitsch R. Proliferation of microglia and astrocytes in the dentate gyrus following entorhinal cortex lesion: a quantitative bromodeoxyuridine-labelling study. Eur J Neurosci 1999; 11: 3359-64
27. Ha BK, Bishop GA, King JS, Burry RW. Corticotropin releasing factor induces proliferation of cerebellar astrocytes. J Neurosci Res 2000; 62: 789-98
28. Heppner FL, Roth K, Nitsch R, Hailer NP. Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells. Glia 1998; 22: 180-8
29. Heinz C, Heise K, Hudde T, Steuhl KP. Mycophenolate mofetil inhibits human Tenon fibroblast proliferation by guanosine depletion. Br J Ophthalmol 2003; 87: 1397-8
30. Raisanen-Sokolowski A, Vuoristo P, Myllarniemi M, Yilmaz S, Kallio E, Hayry P. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transpl Immunol 1995; 3: 342-51
31. Waller J, Brook NR, Nicholson ML. Cardiac allograft vasculopathy: current concepts and treatment. Transpl Int 2003; 16: 367-75
32. Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1998; 9: 2055-66
33. Cohn RG, Mirkovich A, Dunlap B, Burton P, Chiu SH, Eugui E, Caulfield JP. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 1999; 68: 411-18
34. Kim JK, Rathbone MP, Middlemiss PJ, Hughes DW, Smith RW. Purinergic stimulation of astroblast proliferation: guanosine and its nucleotides stimulate cell division in chick astroblasts. J Neurosci Res 1991; 28: 442-55
35. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F, Rathbone MP. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 1999; 25: 93-8
36. Middlemiss PJ, Gysbers JW, Rathbone MP. Extracellular guanosine and guanosine-5'-triphosphate increase: NGF synthesis and release from cultured mouse neopallial astrocytes. Brain Res 1995; 677: 152-6
37. Di Iorio P, Kleywegt S, Ciccarelli R, Traversa U, Andrew CM, Crocker CE, Werstiuk ES, Rathbone MP. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 2002; 38: 179-90
38. Gysbers JW, Rathbone MP. Guanosine enhances NGF-stimulated neurite outgrowth in PC12 cells. Neuroreport 1992; 3: 997-1000
39. Wennberg L, Czech KA, Larsson LC, Mirza B, Bennet W, Song Z, Widner H. Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation 2001; 71: 1797-806
40. Yan J, Xu L, Welsh AM, Chen D, Hazel T, Johe K, Koliatsos VE. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 2006; 24: 1976-85
41. Cottrell BL, Perez-Abadia G, Onifer SM, Magnuson DS, Burke DA, Grossi FV, Francois CG, Barker JH, Maldonado C. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy. Plast Reconstr Surg 2006; 118: 615-23
42. Ahrens N, Salama A, Haas J. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. J Neurol 2001; 248: 713-14
43. Frohman EM, Brannon K, Racke MK, Hawker K. Mycophenolate mofetil in multiple sclerosis. Clin Neuropharmacol 2004; 27: 80-3
44. Mowzoon N, Sussman A, Bradley WG. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. J Neurol Sci 2001; 185: 119-22
45. Piepers S, Van den Berg-Vos R, Van der Pol WL, Franssen H, Wokke J, Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007; 130: 2004-10